Anti-Pseudomonas aeruginosa Vaccines and Therapies: An Assessment of Clinical Trials
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-Pseudomonas aeruginosa Vaccines and Therapies: An Assessment of Clinical Trials
Authors
Keywords
-
Journal
Microorganisms
Volume 11, Issue 4, Pages 916
Publisher
MDPI AG
Online
2023-03-31
DOI
10.3390/microorganisms11040916
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synergy between Human Peptide LL-37 and Polymyxin B against Planktonic and Biofilm Cells of Escherichia coli and Pseudomonas aeruginosa
- (2023) Kylen E. Ridyard et al. Antibiotics-Basel
- Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with chronic obstructive pulmonary disease
- (2022) Josefin Eklöf et al. CLINICAL MICROBIOLOGY AND INFECTION
- Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial
- (2022) Stefan Hagel et al. INTENSIVE CARE MEDICINE
- Structure activity relationship of N-1 substituted 1,5-naphthyrid-2-one analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-9)
- (2022) Sheo B. Singh et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial
- (2022) Adrien Bouglé et al. INTENSIVE CARE MEDICINE
- The effects of antibiotic cycling and mixing on acquisition of antibiotic resistant bacteria in the ICU: A post-hoc individual patient analysis of a prospective cluster-randomized crossover study
- (2022) Pleun J. van Duijn et al. PLoS One
- Blood mRNA biomarkers distinguish variable systemic and sputum inflammation at treatment initiation of inhaled antibiotics in cystic fibrosis: A prospective non-randomized trial
- (2022) Silvia M. Caceres et al. PLoS One
- Efficacy and Safety of Ciprofloxacin Plus Fluocinolone Acetonide Among Patients With Acute Otitis Externa
- (2022) Laurence Chu et al. JAMA Network Open
- Targeted AntiBiotics for Chronic pulmonary diseases (TARGET ABC): can targeted antibiotic therapy improve the prognosis of Pseudomonas aeruginosa-infected patients with chronic pulmonary obstructive disease, non-cystic fibrosis bronchiectasis, and asthma? A multicenter, randomized, controlled, open-label trial
- (2022) Josefin Eklöf et al. Trials
- Distribution and Characteristics of Bacteria Isolated from Cystic Fibrosis Patients with Pulmonary Exacerbation
- (2022) Soroor Erfanimanesh et al. Canadian Journal of Infectious Diseases & Medical Microbiology
- A Double-Blind Randomized Placebo-Controlled Phase 3 Trial of Tobramycin Inhalation Solution in Adults With Bronchiectasis With Pseudomonas aeruginosa Infection
- (2022) Wei-jie Guan et al. CHEST
- Evaluating the emergence of nonsusceptibility among Pseudomonas aeruginosa respiratory isolates from a phase 3 clinical trial for treatment of nosocomial pneumonia (ASPECT-NP)
- (2021) Matthew G. Johnson et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Imipenem/cilastatin/relebactam: A new carbapenem β-lactamase inhibitor combination
- (2021) Hanine Mansour et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Pseudomonas aeruginosa device associated – healthcare associated infections and its multidrug resistance at intensive care unit of University Hospital: polish, 8.5-year, prospective, single-centre study
- (2021) Agnieszka Litwin et al. BMC INFECTIOUS DISEASES
- Association of Intensity of Anti-Pseudomonal Antibiotic Therapy With Risk of Treatment-Emergent Organisms in Cystic Fibrosis Children with Newly Acquired Pseudomonas Aeruginosa
- (2021) Jonathan D Cogen et al. CLINICAL INFECTIOUS DISEASES
- Effect of povidone iodine contact lens disinfecting solution on orthokeratology lens and lens case contamination and organisms in the microbiome of the conjunctiva
- (2021) Sin Wan Cheung et al. Contact Lens & Anterior Eye
- Bacterial Re-Colonization Occurs Early after Lung Transplantation in Cystic Fibrosis Patients
- (2021) Anna Engell Holm et al. Journal of Clinical Medicine
- Single- and Multiple-Ascending-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Polymyxin Derivative SPR206
- (2021) Jon Bruss et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New generation ENaC inhibitors detach cystic fibrosis airway mucus bundles via sodium/hydrogen exchanger inhibition
- (2021) Melania Giorgetti et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Is It Possible to Create Antimicrobial Peptides Based on the Amyloidogenic Sequence of Ribosomal S1 Protein of P. aeruginosa?
- (2021) Sergei Y. Grishin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Long-term amikacin liposome inhalation suspension in cystic fibrosis patients with chronic P. aeruginosa infection
- (2021) Diana Bilton et al. Journal of Cystic Fibrosis
- Preclinical efficacy and clinical safety of clinical‐grade nebulized allogenic adipose mesenchymal stromal cells‐derived extracellular vesicles
- (2021) Meng‐meng Shi et al. Journal of Extracellular Vesicles
- Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese Patients
- (2021) David Busse et al. CLINICAL PHARMACOKINETICS
- Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT
- (2021) Simon C Langton Hewer et al. HEALTH TECHNOLOGY ASSESSMENT
- Safety and pharmacokinetics of Roscovitine (Seliciclib) in cystic fibrosis patients chronically infected with Pseudomonas aeruginosa, a randomized, placebo-controlled study
- (2021) Laurent Meijer et al. Journal of Cystic Fibrosis
- Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial
- (2021) David P Nichols et al. THORAX
- Combining Ivacaftor and Intensive Antibiotics Achieves Limited Clearance of Cystic Fibrosis Infections
- (2021) Samantha L. Durfey et al. mBio
- In Vitro Activity of Ceftazidime-Avibactam Against Isolates from Respiratory and Blood Specimens from Patients with Nosocomial Pneumonia, including Ventilator-Associated Pneumonia, in a Phase 3 Clinical Trial
- (2020) Gregory G. Stone et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Imipenem‐Cilastatin‐Relebactam: A Novel β‐Lactam–β‐Lactamase Inhibitor Combination for the Treatment of Multidrug‐Resistant Gram‐Negative Infections
- (2020) Jordan R. Smith et al. PHARMACOTHERAPY
- Mechanism of Action of Surface Immobilized Antimicrobial Peptides Against Pseudomonas aeruginosa
- (2020) Muhammad Yasir et al. Frontiers in Microbiology
- Intraoperative application of inactivated Pseudomonas aeruginosa in patients undergoing lateral neck dissection for metastatic thyroid cancer: A randomized, parallel group, placebo-controlled trial
- (2020) Li Genpeng et al. SURGERY
- A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)
- (2020) Ivan Titov et al. CLINICAL INFECTIOUS DISEASES
- Outcomes in Participants with Renal Impairment from a Phase 3 Clinical Trial for Ceftolozane/Tazobactam Treatment of Nosocomial Pneumonia (ASPECT-NP)
- (2020) Jennifer A. Huntington et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamic Evaluation of MRX-8, a Novel Polymyxin, in the Neutropenic Mouse Thigh and Lung Infection Models against Gram-Negative Pathogens
- (2020) Alexander J. Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Microbial epidemiology and risk factors for relapse in gram-negative bacteria catheter-related bloodstream infection with a pilot prospective study in patients with catheter removal receiving short-duration of antibiotic therapy
- (2020) Bhitta Surapat et al. BMC INFECTIOUS DISEASES
- Efficacy and safety of TOBI Podhaler® in Pseudomonas aeruginosa-infected bronchiectasis patients: iBEST study
- (2020) Michael R. Loebinger et al. EUROPEAN RESPIRATORY JOURNAL
- Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
- (2020) Matteo Bassetti et al. LANCET INFECTIOUS DISEASES
- Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial
- (2020) Richard G Wunderink et al. LANCET INFECTIOUS DISEASES
- Pseudomonas aeruginosa Biofilms
- (2020) Minh Tam Tran Thi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of Tris-CaEDTA as an adjuvant with nebulised tobramycin in cystic fibrosis patients with Pseudomonas aeruginosa lung infections: A randomised controlled trial
- (2020) Ramaa Puvvadi et al. Journal of Cystic Fibrosis
- Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials
- (2019) Charles S Haworth et al. Lancet Respiratory Medicine
- The clinical efficacy of intravenous IgM-enriched immunoglobulin (pentaglobin) in sepsis or septic shock: a meta-analysis with trial sequential analysis
- (2019) Jie Cui et al. Annals of Intensive Care
- Antibiotic Therapy for Pseudomonas aeruginosa Bloodstream Infections: How Long is Long Enough?
- (2019) Valeria Fabre et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetic-pharmacodynamic analysis of ciprofloxacin in elderly Chinese patients with lower respiratory tract infections caused by Gram-negative bacteria
- (2019) Xiao-Yan Gai et al. CHINESE MEDICAL JOURNAL
- Post-traumatic osteomyelitis in Middle East war-wounded civilians: resistance to first-line antibiotics in selected bacteria over the decade 2006–2016
- (2019) Fabien Fily et al. BMC INFECTIOUS DISEASES
- Characterization of β-lactamase content of ceftazidime-resistant pathogens recovered during the pathogen-directed Phase 3 trial (REPRISE) for ceftazidime-avibactam: Correlation of efficacy against β-lactamase producers
- (2019) Rodrigo E. Mendes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High incidence of multiresistant bacterial isolates from bloodstream infections in trauma emergency department and intensive care unit in Serbia
- (2019) Olivera Djuric et al. ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA
- Safety, Tolerability, Pharmacokinetics, and Drug Interaction Potential of SPR741, An Intravenous Potentiator, After Single and Multiple Ascending Doses and When Combined with Beta-Lactam Antibiotics in Healthy Subjects
- (2019) Paul B. Eckburg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Randomized controlled study of aerosolized hypertonic xylitol versus hypertonic saline in hospitalized patients with pulmonary exacerbation of cystic fibrosis
- (2019) Sachinkumar Singh et al. Journal of Cystic Fibrosis
- Human antibody repertoire frequently includes antibodies to a bacterial biofilm associated protein
- (2019) Stefan Ryser et al. PLoS One
- RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections
- (2019) Johann Motsch et al. CLINICAL INFECTIOUS DISEASES
- Association of CFH polymorphism with susceptibility to sepsis caused by Pseudomonas aeruginosa in Chinese Han populations: A multi-center study
- (2019) Jia Li et al. GENE
- Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis
- (2019) Diana Bilton et al. Journal of Cystic Fibrosis
- Manuka honey sinus irrigations in recalcitrant chronic rhinosinusitis: phase 1 randomized, single‐blinded, placebo‐controlled trial
- (2019) Mian Li Ooi et al. International Forum of Allergy & Rhinology
- Polymyxin B analog SPR741 potentiates antibiotics against Gram-negative bacteria and uniquely perturbs the outer membrane
- (2019) Shawn French et al. ACS Infectious Diseases
- Changes in the prevalence of causative pathogens isolated from severe burn patients from 2012 to 2017
- (2019) Jin Ju Park et al. BURNS
- Microbiology and clinical characteristics of industrial oil burns
- (2019) Devin C. Kelly et al. BURNS
- Clinical and microbiological outcomes of photodynamic and systemic antimicrobial therapy in smokers with peri-implant inflammation
- (2019) Modhi Al Deeb et al. Photodiagnosis and Photodynamic Therapy
- Efficacy and safety of tobramycin inhalation powder in bronchiectasis patients with P. aeruginosa infection: Design of a dose-finding study (iBEST-1)
- (2019) Michael R. Loebinger et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Development of a novel hybrid antimicrobial peptide for targeted killing of Pseudomonas aeruginosa
- (2019) Hyun Kim et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Microbiology of Cystic Fibrosis Airway Disease
- (2019) Ana C. Blanchard et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- The Role of Pseudomonas aeruginosa Lipopolysaccharide in Bacterial Pathogenesis and Physiology
- (2019) Steven M. Huszczynski et al. Pathogens
- Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis: The Optimize Randomized Trial
- (2018) Nicole Mayer-Hamblett et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pharmacokinetics of ciprofloxacin in children with complicated urinary tract infection: results of a multicenter population pharmacokinetic study.
- (2018) Kevin Meesters et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Ceftazidime-Avibactam against Isolates from Patients in a Phase 3 Clinical Trial for Treatment of Complicated Intra-abdominal Infections
- (2018) Gregory G. Stone et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Activity of Murepavadin Tested against Clinical Isolates of Pseudomonas aeruginosa from the United States, Europe, and China
- (2018) Helio S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Safety of Intravenous Murepavadin Infusion in Healthy Adult Subjects Administered Single and Multiple Ascending Doses
- (2018) Achim Wach et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Murepavadin, a novel antipseudomonal antibiotic: Pharmacokinetics, tolerability and safety in subjects with mild, moderate, and severe renal function impairment
- (2018) Glenn E. Dale et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Intrapulmonary percussive ventilation improves lung function in cystic fibrosis patients chronically colonized with Pseudomonas aeruginosa: a pilot cross-over study
- (2018) Jozef Dingemans et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Burden and Risk Factors for Pseudomonas aeruginosa Community-acquired Pneumonia: a Multinational Point Prevalence Study of Hospitalised Patients
- (2018) Marcos I. Restrepo et al. EUROPEAN RESPIRATORY JOURNAL
- Murepavadin: a new antibiotic class in the pipeline
- (2018) Ignacio Martin-Loeches et al. Expert Review of Anti-Infective Therapy
- Urinary concentrations and antimicrobial activity of tobramycin in healthy volunteers receiving a single oral dose of a novel formulation for improved absorption
- (2018) Maria Loose et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Clinical activity of ceftazidime/avibactam against MDR Enterobacteriaceae and Pseudomonas aeruginosa: pooled data from the ceftazidime/avibactam Phase III clinical trial programme
- (2018) Gregory G Stone et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- OUP accepted manuscript
- (2018) JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Eradication of early P. aeruginosa infection in children
- (2018) Felix Ratjen et al. Journal of Cystic Fibrosis
- KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa
- (2018) R. Jain et al. Journal of Cystic Fibrosis
- The effects of antibiotic cycling and mixing on antibiotic resistance in intensive care units: a cluster-randomised crossover trial
- (2018) Pleun Joppe van Duijn et al. LANCET INFECTIOUS DISEASES
- Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial
- (2018) Antoni Torres et al. LANCET INFECTIOUS DISEASES
- Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance
- (2018) Carolina Garcia-Vidal et al. PLoS One
- A Prospective Trial of Nebulized Amikacin in the Treatment of Bronchiectasis Exacerbation
- (2018) Yirepanjaing Ailiyaer et al. RESPIRATION
- Early increase of VEGF-A is associated with resolution of ventilator-associated pneumonia: Clinical and experimental evidence
- (2018) Ioannis Strouvalis et al. RESPIROLOGY
- Pyoverdine, a siderophore from Pseudomonas aeruginosa, translocates into C. elegans, removes iron, and activates a distinct host response
- (2018) Donghoon Kang et al. Virulence
- Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides
- (2018) Lydia C. Powell et al. npj Biofilms and Microbiomes
- Phase 1 study of MEDI3902, an investigational anti–Pseudomonas aeruginosa PcrV and Psl bispecific human monoclonal antibody, in healthy adults
- (2018) S.O. Ali et al. CLINICAL MICROBIOLOGY AND INFECTION
- Metagenome analysis of Russian and Georgian Pyophage cocktails and a placebo-controlled safety trial of single phage versus phage cocktail in healthy Staphylococcus aureus carriers
- (2018) Shawna McCallin et al. ENVIRONMENTAL MICROBIOLOGY
- Pseudomonas aeruginosa bacteremia: resistance to antibiotics, risk factors, and patient mortality
- (2018) Astra Vitkauskienė et al. Medicina-Lithuania
- Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections
- (2018) Christopher H. Goss et al. Science Translational Medicine
- Small Molecule Inhibitor of Type Three Secretion System Belonging to a Class 2,4-disubstituted-4H-[1,3,4]-thiadiazine-5-ones Improves Survival and Decreases Bacterial Loads in an Airway Pseudomonas aeruginosa Infection in Mice
- (2018) Anna B. Sheremet et al. Biomed Research International
- Assessment of device-associated infection rates in four teaching hospitals, Islamic Republic of Iran
- (2018) Shirin Afhami et al. EASTERN MEDITERRANEAN HEALTH JOURNAL
- Single-Center Evaluation of the Pharmacokinetics of WCK 5222 (Cefepime-Zidebactam Combination) in Subjects with Renal Impairment
- (2018) Richard A. Preston et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
- (2018) Zheng Pang et al. BIOTECHNOLOGY ADVANCES
- Multidrug resistant Pseudomonas aeruginosa in Estonian hospitals
- (2018) Kaidi Telling et al. BMC INFECTIOUS DISEASES
- Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial
- (2018) Simon Portsmouth et al. LANCET INFECTIOUS DISEASES
- Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial
- (2018) Patrick Jault et al. LANCET INFECTIOUS DISEASES
- Changes in Prevalence of Health Care–Associated Infections in U.S. Hospitals
- (2018) Shelley S. Magill et al. NEW ENGLAND JOURNAL OF MEDICINE
- The efficacy and safety of tazobactam/ceftolozane in combination with metronidazole in Japanese patients with complicated intra-abdominal infections
- (2018) Hiroshige Mikamo et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Maximally effective dosing regimens of meropenem in patients with septic shock
- (2017) Fredrik Sjövall et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Reduced survival in adult cystic fibrosis despite attenuated lung function decline
- (2017) Claire Keating et al. Journal of Cystic Fibrosis
- Bloodstream infections in pediatric patients with acute leukemia: Emphasis on gram-negative bacteria infections
- (2017) Fu-Chun Kuo et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- The Mla pathway is critical for Pseudomonas aeruginosa resistance to outer membrane permeabilization and host innate immune clearance
- (2017) Jason Munguia et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study
- (2017) Alfonso Esposito et al. Frontiers in Microbiology
- Microbiology in burns patients with blood stream infections: trends over time and during the course of hospitalization
- (2017) Dolores Sousa et al. Infectious Diseases
- Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infection
- (2017) Jessica E. Pittman et al. PLoS One
- A High-Affinity Native Human Antibody Disrupts Biofilm from Staphylococcus aureus Bacteria and Potentiates Antibiotic Efficacy in a Mouse Implant Infection Model
- (2016) Angeles Estellés et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Surveillance of antibiotic susceptibility in a Swedish Burn Center 1994–2012
- (2016) Jian Fransén et al. BURNS
- Role of CFTR in epithelial physiology
- (2016) Vinciane Saint-Criq et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- A Case-Control Study Assessing the Impact of Nonventilated Hospital-Acquired Pneumonia on Patient Outcomes
- (2016) Scott T. Micek et al. CHEST
- Major Transcriptome Changes Accompany the Growth of Pseudomonas aeruginosa in Blood from Patients with Severe Thermal Injuries
- (2016) Cassandra Kruczek et al. PLoS One
- Targeting the Type Three Secretion System in Pseudomonas aeruginosa
- (2016) Ahalieyah Anantharajah et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Pseudomonas aeruginosa proteolytically alters the interleukin 22-dependent lung mucosal defense
- (2016) Antoine Guillon et al. Virulence
- Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals — United States, 2014
- (2016) Lindsey M. Weiner et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- IgM-Enriched Immunoglobulin Attenuates Systemic Endotoxin Activity in Early Severe Sepsis: A Before-After Cohort Study
- (2016) Saskia Wand et al. PLoS One
- Clinical applications of pulmonary delivery of antibiotics
- (2015) Patrick A. Flume et al. ADVANCED DRUG DELIVERY REVIEWS
- Disarming Pseudomonas aeruginosa Virulence Factor LasB by Leveraging a Caenorhabditis elegans Infection Model
- (2015) Jie Zhu et al. CHEMISTRY & BIOLOGY
- Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey
- (2015) E.M. Trecarichi et al. CLINICAL MICROBIOLOGY AND INFECTION
- Healthcare-Associated Infections in Pediatric Intensive Care Units in Turkey: a National Point-Prevalence Survey
- (2015) Eda Kepenekli et al. JAPANESE JOURNAL OF INFECTIOUS DISEASES
- Pseudomonas aeruginosaExoT Induces Mitochondrial Apoptosis in Target Host Cells in a Manner That Depends on Its GTPase-activating Protein (GAP) Domain Activity
- (2015) Stephen J. Wood et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Small Molecule Disruption of Quorum Sensing Cross-Regulation in Pseudomonas aeruginosa Causes Major and Unexpected Alterations to Virulence Phenotypes
- (2015) Michael A. Welsh et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Composition, function, and regulation of T6SS in Pseudomonas aeruginosa
- (2015) Lihua Chen et al. MICROBIOLOGICAL RESEARCH
- Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation
- (2015) M. Kikuchi et al. Transplant Infectious Disease
- Clinical outcomes associated with Staphylococcus aureus and Pseudomonas aeruginosa airway infections in adult cystic fibrosis patients
- (2015) Heather G. Ahlgren et al. BMC Pulmonary Medicine
- Correction: The Role of ExoS in Dissemination of Pseudomonas aeruginosa during Pneumonia
- (2015) Stephanie M. Rangel et al. PLoS Pathogens
- Pseudomonas Exotoxin A: optimized by evolution for effective killing
- (2015) Marta Michalska et al. Frontiers in Microbiology
- Contribution of the platelet activating factor signaling pathway to cerebral microcirculatory dysfunction during experimental sepsis by ExoU producingPseudomonas aeruginosa
- (2015) Maria Cristina Plotkowski et al. Pathogens and Disease
- How to treat VAP due to MDR pathogens in ICU patients
- (2014) José Garnacho-Montero et al. BMC INFECTIOUS DISEASES
- Global Prospective Epidemiologic and Surveillance Study of Ventilator-Associated Pneumonia due to Pseudomonas aeruginosa*
- (2014) Marin H. Kollef et al. CRITICAL CARE MEDICINE
- Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia
- (2014) Y.-A. Que et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Nitrite modulates bacterial antibiotic susceptibility and biofilm formation in association with airway epithelial cells
- (2014) Anna C. Zemke et al. FREE RADICAL BIOLOGY AND MEDICINE
- Viruses versus bacteria--novel approaches to phage therapy as a tool against multidrug-resistant pathogens
- (2014) T. M. Viertel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Impact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients: A 12-year single institution study
- (2014) Susan K. Seo et al. JOURNAL OF INFECTION
- The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients
- (2014) Michael J. Satlin et al. LEUKEMIA & LYMPHOMA
- Bloodstream Infections in Patients With Solid Tumors
- (2014) Mar Marín et al. MEDICINE
- The protective effects of IgM-enriched immunoglobulin and erythropoietin on the lung and small intestine tissues of rats with induced sepsis: Biochemical and histopathological evaluation
- (2014) Irem Ates et al. PHARMACEUTICAL BIOLOGY
- A multifunctional bispecific antibody protects against Pseudomonas aeruginosa
- (2014) A. DiGiandomenico et al. Science Translational Medicine
- The ADP-Ribosyltransferase Domain of the Effector Protein ExoS Inhibits Phagocytosis of Pseudomonas aeruginosa during Pneumonia
- (2014) S. M. Rangel et al. mBio
- Respiratory infections in patients undergoing mechanical ventilation
- (2014) Jordi Rello et al. Lancet Respiratory Medicine
- Nosocomial infection characteristics in a burn intensive care unit: Analysis of an eleven-year active surveillance
- (2013) Oral Öncül et al. BURNS
- Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis
- (2013) K.J. Psoter et al. CLINICAL MICROBIOLOGY AND INFECTION
- Inhaled antibiotics for the treatment of chronic bronchopulmonaryPseudomonas aeruginosainfection in cystic fibrosis: systematic review of randomised controlled trials
- (2013) Luis Máiz et al. EXPERT OPINION ON PHARMACOTHERAPY
- Anti-PcrV antibody in cystic fibrosis: A novel approach targetingPseudomonas aeruginosaairway infection
- (2013) Carlos E. Milla et al. PEDIATRIC PULMONOLOGY
- A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of aPseudomonas aeruginosahybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers
- (2013) Kerstin Westritschnig et al. Human Vaccines & Immunotherapeutics
- Prevalence and antimicrobial susceptibility of respiratory pathogens in patients with cystic fibrosis
- (2012) Vilma Almeida Paixão et al. Brazilian Journal of Infectious Diseases
- Phenotypes selected during chronic lung infection in cystic fibrosis patients: implications for the treatment ofPseudomonas aeruginosabiofilm infections
- (2012) Oana Ciofu et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
- (2012) Gerd Döring et al. Journal of Cystic Fibrosis
- Identification of broadly protective human antibodies toPseudomonas aeruginosaexopolysaccharide Psl by phenotypic screening
- (2012) Antonio DiGiandomenico et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Pseudomonas aeruginosa Pili and Flagella Mediate Distinct Binding and Signaling Events at the Apical and Basolateral Surface of Airway Epithelium
- (2012) Iwona Bucior et al. PLoS Pathogens
- Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis withPseudomonasAirway Infection
- (2011) Bruce C. Trapnell et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Role of Exopolysaccharides in Pseudomonas aeruginosa Biofilm Formation and Architecture
- (2011) Aamir Ghafoor et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Cystic Fibrosis Transmembrane Conductance Regulator Intracellular Processing, Trafficking, and Opportunities for Mutation-Specific Treatment
- (2011) Mark P. Rogan et al. CHEST
- Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia
- (2011) Q. Lu et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Prosthetic Joint Infection Caused by Gram-Negative Organisms
- (2011) Benjamin Zmistowski et al. JOURNAL OF ARTHROPLASTY
- Pseudomonas aeruginosa Alkaline Protease Blocks Complement Activation via the Classical and Lectin Pathways
- (2011) A. J. Laarman et al. JOURNAL OF IMMUNOLOGY
- A Novel Polymyxin Derivative That Lacks the Fatty Acid Tail and Carries Only Three Positive Charges Has Strong Synergism with Agents Excluded by the Intact Outer Membrane
- (2010) M. Vaara et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sodium Nitrite-Mediated Killing of the Major Cystic Fibrosis Pathogens Pseudomonas aeruginosa, Staphylococcus aureus, and Burkholderia cepacia under Anaerobic Planktonic and Biofilm Conditions
- (2010) T. A. Major et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Changing Microbial Epidemiology in Cystic Fibrosis
- (2010) J. J. LiPuma CLINICAL MICROBIOLOGY REVIEWS
- Pseudomonas aeruginosa Cytotoxin ExoU Is Injected into Phagocytic Cells during Acute Pneumonia
- (2010) M. H. Diaz et al. INFECTION AND IMMUNITY
- Full Virulence ofPseudomonas aeruginosaRequires OprF
- (2010) Laurène Fito-Boncompte et al. INFECTION AND IMMUNITY
- Protein secretion systems in Pseudomonas aeruginosa: A wealth of pathogenic weapons
- (2010) Sophie Bleves et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Extracellular enzymes affect biofilm formation of mucoid Pseudomonas aeruginosa
- (2010) P. Tielen et al. MICROBIOLOGY-SGM
- Hospital-Acquired Infections Due to Gram-Negative Bacteria
- (2010) Anton Y. Peleg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Return of FEV1after pulmonary exacerbation in children with cystic fibrosis
- (2010) Don B. Sanders et al. PEDIATRIC PULMONOLOGY
- Quorum Sensing Inhibition Selects for Virulence and Cooperation in Pseudomonas aeruginosa
- (2010) Thilo Köhler et al. PLoS Pathogens
- Blood Stream Infections in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Reemergence of Gram-Negative Rods and Increasing Antibiotic Resistance
- (2009) Malgorzata Mikulska et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Gram‐Negative Prosthetic Joint Infections: Risk Factors and Outcome of Treatment
- (2009) Pang‐Hsin Hsieh et al. CLINICAL INFECTIOUS DISEASES
- Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis
- (2009) D. L. MacLeod et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Aminoglycoside therapy against Pseudomonas aeruginosa in cystic fibrosis: A review
- (2009) Felix Ratjen et al. Journal of Cystic Fibrosis
- Crystal Structure of the LasA Virulence Factor from Pseudomonas aeruginosa: Substrate Specificity and Mechanism of M23 Metallopeptidases
- (2009) James Spencer et al. JOURNAL OF MOLECULAR BIOLOGY
- The type III secretion system of Pseudomonas aeruginosa: infection by injection
- (2009) Alan R. Hauser NATURE REVIEWS MICROBIOLOGY
- Incidence of Pseudomonas aeruginosa Bacteremia: A Population-Based Study
- (2008) Majdi N. Al-Hasan et al. AMERICAN JOURNAL OF MEDICINE
- Effects of Antibiotics on Quorum Sensing in Pseudomonas aeruginosa
- (2008) M. E. Skindersoe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Polymicrobial Prosthetic Joint Infections: Risk Factors and Outcome
- (2008) Camelia E. Marculescu et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- Dynamics of Pseudomonas aeruginosa genome evolution
- (2008) K. Mathee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now